Genetesis
Latest round
- Series C
Last raised
- Oct 2022
Total raised
- $50M
Investors
- 13
About Genetesis
Genetesis, Inc specializes in advanced cardiac imaging solutions centered around its flagship product, CardioFlux.Genetesis specializes in advanced cardiac imaging solutions, primarily through its flagship product, CardioFlux. This innovative device utilizes magnetocardiography (MCG) technology to non-invasively measure and visualize the magnetic signals generated by the electrical currents in the heart. CardioFlux enables the rapid detection of functionally significant ischemia within a five-minute scanning window, significantly reducing the time and complexity associated with traditional cardiac assessments such as stress testing and observation periods. The device is designed to streamline workflows in clinical settings, thus improving patient care by allowing healthcare providers to make quicker and more informed decisions about treatment.Genetesis generates revenue through the sale and deployment of its CardioFlux MCG technology within healthcare facilities. The company typically engages in B2B transactions, partnering with hospitals and diagnostic centers to integrate CardioFlux into their existing cardiac imaging workflows. This partnership model allows healthcare providers to obtain the technology either through direct purchase or leasing agreements, facilitating access to advanced diagnostic capabilities without significant upfront capital expenses. Strategic collaborations with other healthcare providers enhance the firm's market presence and assist in establishing standard care protocols. The company plans to expand its market reach, focusing on new geographic regions to enhance its presence in the healthcare industry.
Who invested in Genetesis
13 investors across 5 rounds
See all investors in Genetesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genetesis
Who invested in Genetesis?
Genetesis has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genetesis raised?
Genetesis has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Genetesis last raise money?
Genetesis's most recent round on record is a Series C, in Oct 2022.
What does Genetesis do?
Genetesis, Inc specializes in advanced cardiac imaging solutions centered around its flagship product, CardioFlux.
Where is Genetesis headquartered?
Genetesis is headquartered in Mason, US.
Which VCs invest in companies like Genetesis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Genetesis's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Genetesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.